The C-peptide response to a standard mixed meal in a group of Brazilian type 1 diabetic patients.

In order to analyze the different parameters used in the interpretation of C-peptide response in a functional test, we compared a group of 26 type 1 diabetics aged 21.1 +/- 8.2 years, with a diabetes duration of 7.9 +/- 6.7 months, with a group of 24 non-diabetic subjects aged 25.0 +/- 4.4 years. A standard mixed meal of 317 kcal was used as a stimulus. Blood sampling for C-peptide determinations was performed at regular intervals. Although all the studied C-peptide variables were significantly lower in the diabetic group (P < 0.0001), some overlapping of parameters was observed between the two groups. The highest degree of overlapping was found for basal value (BV) (30.8%) and percent increase (42.31%), and the lowest for incremental area, absolute increase, peak value (PV) (3.8%), and total area (7.7%) (chi 2 = 31.6, P < 0.0001). We did not observe a definite pattern in the time of maximum response among the 21 diabetics who showed an increase in C-peptide levels after the stimulus. In this group, however, there was a highly significant number of late responses (120 min) (chi 2 = 5.7, P < 0.002). Although BV showed a significant correlation with PV (rS = 0.95, P < 0.0001), the basal levels of C-peptide did not differentiate the groups with and without response to the stimulus. We conclude that the diabetic group studied showed delayed and reduced C-peptide responses, and that the functional test can be an important tool for the evaluation of residual beta cell function.

• Publication year

  1997

• Venue

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

• Publication date

  1997-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1590/S0100-879X1997001000005PMID 9496433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-Year Follow-up Study of C-Peptide Secretion in Newly Diagnosed Type I Diabetics: Relations to HLA- Phenotype, Insulin Requirement and Metabolic Control

  2009cited by this paper
• Influence of polyethylene glycol (PEG) extraction on the C-peptide determination in sera from insulin-dependent diabetic patients with circulating insulin antibodies.

  2009cited by this paper
• Office Guide to Diagnosis and Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1995cited by this paper
• The Diabetes Control and Complications Trial (DCCT).

  1994cited by this paper
• Factors predicting course of beta-cell function in IDDM.

  1992cited by this paper
• Factors Predicting Course of β-cell Function in IDDM

  1992cited by this paper
• Homogeneity in Pattern of Decline of β-Cell Function in IDDM: Prospective study of 204 consecutive cases followed for 7.4 yr

  1992cited by this paper
• Plasma C-Peptide Levels and Clinical Remissions in Recent-Onset Type I Diabetic Patients Treated With Cyclosporin A and Insulin

  1990cited by this paper
• Blood Glucose Area Under the Curve: Methodological Aspects

  1990cited by this paper
• Factors influencing the magnitude, duration, and rate of fall of B-cell function in Type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis

  1988cited by this paper
• Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control

  1988cited by this paper
• Correlation Between Minimal Secretory Capacity of Pancreatic β-Cells and Stability of Diabetic Control

  1988cited by this paper
• Factors affecting and patterns of residual insulin secretion during the first year of Type 1 (insulin-dependent) diabetes mellitus in children

  1987cited by this paper
• Residual beta-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve.

  1987cited by this paper
• Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.

  1987cited by this paper
• Correlations Between Fasting Plasma C-Peptide, Glucagon-Stimulated Plasma C-Peptide, and Urinary C-Peptide in Insulin-Treated Diabetics

  1987influential reference
• Residual B-cell function in insulin-dependent (type I) diabetics with and without retinopathy

  1986cited by this paper
• Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.

  1985cited by this paper
• Metabolic Control in 131 Juvenile-onset Diabetic Patients as Measured by HbA1c: Relation to Age, Duration, C-Peptide, Insulin Dose, and One or Two Insulin Injections

  1982cited by this paper
• Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus

  1982cited by this paper
• C-peptide reserve in insulin-dependent diabetes

  1980cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• C-peptide Response to Glucagon: A Test for the Residual β-cell Function in Diabetes Mellitus

  1977influential reference
• Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-peptide response to intravenous glucagon

  1977cited by this paper
• B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment

  1977cited by this paper
• C-Peptide in children with juvenile diabetes

  1976cited by this paper

• Continuous Glucose Monitoring to Compare Glycemic Patterns and Variability in Insulin-Treated Pancreatic Diabetes Mellitus with Type 1 Diabetes and a Clue to the Influence of Pancreatic Enzyme Replacement

  2025cites this paper
• C-Peptid als Surrogatparameter einer residualen Beta-Zellfunktion bei Typ-1-Diabetes und ihre mögliche klinische Bedeutung

  2024cites this paper
• Glycemic variability in chronic calcific pancreatitis with diabetes mellitus and its possible determinants.

  2024cites this paper
• Cholesterol and glucose profiles according to different fasting C-peptide levels: a cross-sectional analysis in a healthy cohort from the Czech Republic.

  2021cites this paper
• Post-usual meal C-peptide as a reliable and practical alternative to C-peptide following glucagon or standardized mixed-meal for β-cell reserve: a comparative study between three stimulatory methods in different types of diabetes

  2021cites this paper
• A Practical Review of C-Peptide Testing in Diabetes

  2017cites this paper
• Metabolic outcomes of islet transplantation and correlation of graft function with hepatic imaging and immune response

  2015cites this paper
• The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level—a pilot study

  2011cites this paper
• Persistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells.

  2010cites this paper
• Avaliação da função pancreática em pacientes com diabetes melito tipo 1 de acordo com a duração da doença

  2009cites this paper
• [Pancreatic function assessment in type 1 diabetes mellitus patients according to disease duration].

  2009cites this paper
• [C-peptide residual secretion makes difference on type 1 diabetes management?].

  2008cites this paper
• C-Peptide: Much More Than a Byproduct of Insulin Biosynthesis

  2004cites this paper
• Gliclazide and bedtime insulin are more efficient than insulin alone for type 2 diabetic patients with sulfonylurea secondary failure.

  2001cites this paper